Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thioredoxin and ventricular remodeling.

Tetsuro Ago1, Junichi Sadoshima

  • 1Cardiovascular Research Institute, Department of Cell Biology and Molecular Medicine, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, 185 South Orange Avenue, Medical Science Building G-609, Newark, NJ 07103, USA.

Journal of Molecular and Cellular Cardiology
|September 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

YAP plays a critical role in myocardial recovery from myocarditis by suppressing IFN-γ signaling pathway.

Cardiovascular research·2026
Same author

Reduced Myocardial Serine Synthesis Impairs Functional, Metabolic, and Redox Adaptations to Cardiac Stress.

bioRxiv : the preprint server for biology·2026
Same author

A decline in skeletal muscle NOX4 abrogates exercise-induced adaptive homeostasis and exacerbates biological aging.

Science advances·2026
Same author

YAP mediates activation of the serine synthesis pathway in the heart during pressure overload.

Journal of molecular and cellular cardiology·2026
Same author

Decoding the Mitochondrial Translation-Stress Axis: Is TARS2 the Missing Link in DCM Pathogenesis?

JACC. Basic to translational science·2026
Same author

Perm1 enhances Nrf2-driven antioxidant defense through Keap1 oxidation during myocardial ischemia/reperfusion injury.

JCI insight·2026

Reactive oxygen species (ROS) contribute to heart remodeling after myocardial infarction. Thioredoxin, a key antioxidant, inhibits this remodeling by scavenging ROS and modulating cellular functions, offering a potential therapeutic target for heart failure.

Area of Science:

  • Cardiovascular Biology
  • Oxidative Stress Research
  • Molecular Cardiology

Background:

  • Reactive oxygen species (ROS) are implicated in post-myocardial infarction ventricular remodeling and heart failure development.
  • Antioxidants mitigate ROS, preserving cellular redox balance and inhibiting cardiac remodeling.
  • Thioredoxin is a crucial cardiac antioxidant involved in signaling and transcription regulation.

Purpose of the Study:

  • To review the cardiac effects of thioredoxin.
  • To elucidate the mechanisms by which thioredoxin inhibits ventricular remodeling.
  • To highlight thioredoxin's role in mitigating heart failure progression.

Main Methods:

  • Literature review of studies on thioredoxin, ROS, and cardiac remodeling.
  • Analysis of molecular and cellular mechanisms of thioredoxin action.

Related Experiment Videos

  • Synthesis of evidence on thioredoxin's regulatory pathways (transcription, localization, etc.).

    • Main Results:

    • Thioredoxin acts as a major antioxidant in the heart.
    • It interacts with signaling molecules and transcription factors to modulate cellular functions.
    • Its activity is controlled by multiple regulatory mechanisms.

    Conclusions:

    • Thioredoxin plays a protective role against ventricular remodeling.
    • Understanding thioredoxin's regulatory mechanisms is key to its therapeutic potential.
    • Targeting thioredoxin may offer a novel strategy for treating heart failure post-myocardial infarction.